Dipexium Pharmaceuticals Inc. (NASDAQ:DPRX) shares traded down 2.8% on Thursday . The stock traded as low as $12.20 and last traded at $12.35, with a volume of 69,666 shares traded. The stock had previously closed at $12.70.

Separately, Zacks Investment Research raised shares of Dipexium Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Tuesday, June 14th.

The firm’s market capitalization is $137.36 million. The stock’s 50 day moving average is $11.42 and its 200 day moving average is $10.16.

Dipexium Pharmaceuticals (NASDAQ:DPRX) last issued its quarterly earnings data on Thursday, August 4th. The company reported ($0.52) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.54) by $0.02. Equities analysts expect that Dipexium Pharmaceuticals Inc. will post ($2.10) earnings per share for the current year.

Dipexium Pharmaceuticals, Inc is a late-stage pharmaceutical company. The Company is focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a first-in-class, broad spectrum, topical antibiotic. Locilex is focused on the treatment of mild infections of diabetic foot ulcers (Mild DFI).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.